Inovio definition

Inovio has the meaning set forth in the introductory paragraph.
View Source
Inovio or the “Company” means nominal defendant Inovio Pharmaceuticals, Inc. and its affiliates, subsidiaries, predecessors, successors, and assigns.
View Source
Inovio means Inovio Pharmaceuticals, Inc.
View Source

Examples of Inovio in a sentence

  • Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to , Attention: and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Inovio Pharmaceuticals, Inc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ Pike, Suite 110, Plymouth Meeting, Pennsylvania 19462, Attention: Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

  • Inovio Biomedical Corporation has caused this Warrant to be executed by its duly authorized officer and attested by its Secretary.

  • MedImmune shall be entitled to deduct any such tax, levy or charge actually paid from royalty or other payment due Inovio or be promptly reimbursed by Inovio if no further payments are due Inovio.

  • For avoidance of doubt, MedImmune retains all rights to use MedImmune Improvements to Inovio Background IP Rights.

  • No shares of Inovio Common Stock are owned or held by any Subsidiary of Inovio.

  • Inovio and its Subsidiaries are in compliance in all material respects with the terms of Inovio Permits.

  • Inovio shall execute, or shall cause its licensor to execute, such authorizations and other documents and take such other actions as may be reasonably requested by MedImmune to obtain such Patent Term Extensions, including designating MedImmune as its agent for such purpose as provided in 35 U.S.C.

  • Section 3.8(b) of the Inovio Disclosure Letter sets forth as of the date hereof each of the Inovio Permits and lists all regulatory filing requirements that are required to be filed within six months after the Closing Date in order to maintain the Permits.

  • To the Knowledge of Inovio, there is no information regarding prior art, prior use in commerce, failure to join an inventor, or another basis on which to conclude that any invention disclosed in a patent application included in the Registered Inovio Intellectual Property is not patentable.

  • Within forty five (45) days after the Effective Date, in consideration for rights granted herein, MedImmune shall pay to Inovio a one-time, non-refundable, non-creditable signing and exclusivity fee of Twenty Seven and one-half Million US Dollars (US$27,500,000).